PharmaCorp Rx Stock

PharmaCorp Rx EBIT per Share

The EBIT per Share of PharmaCorp Rx (PCRX.V) as of Sep 5, 2026 is -0.02 CAD. In the previous year, EBIT per Share was -0.01 CAD — a change of 35.26% (lower).

EBIT per Share

-0.02CAD

YoY

35.26%

Last updated:

EBIT per Share of PharmaCorp Rx is 2026 -0.02 CAD. EBIT per Share of PharmaCorp Rx was 2025 -0.01 CAD. It decreases by 35.26% lower compared to the previous year.

The PharmaCorp Rx EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.00 CAD
Jan 1, 2022
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.02 CAD
Jan 1, 2025 (e)
0.00 CAD
Jan 1, 2026 (e)
0.00 CAD
Jan 1, 2027 (e)
0.00 CAD
The PharmaCorp Rx EBIT per Share history
YEAREBIT per ShareYoY
est0.00CAD—
est0.00CAD—
est0.00CAD-100.00%
-0.02CAD+35.26%
-0.01CAD-16.97%
-0.02CAD+2,511.88%
-0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

EBIT per Share of PharmaCorp Rx is -0.02 CAD in 2026.

EBIT per Share of PharmaCorp Rx changed from -0.01 CAD to -0.02 CAD, representing a 35.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — PharmaCorp Rx

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCorp Rx